Home | Welcome to Contract Pharma   
Last Updated Wednesday, July 30 2014
Print RSS Feed

Breaking News

Related Searches:
January 22, 2010
Ray Russo has been appointed vice president, Primary Care Business Unit, at Shionogi Pharma, Inc.   Read More »
January 21, 2010
Patheon began construction of a new pharmaceutical development center at its existing manufacturing facility in Bourgoin-Jallieu, France.  Read More »
January 21, 2010
Merck’s HIV treatment vicriviroc did not meet the primary efficacy endpoint in two Phase III studies involving patients previously treated with other HIV medicines.  Read More »
January 21, 2010
AlphaRx Inc.’s licensee, Gaia BioPharma Ltd., has signed an agreement with a CMO to manufacture GAI-122 for use in Phase I and II trials.  Read More »
January 21, 2010
NextPharma Technologies’ expansion of its Cold Chain and Logistics (CLS) business in Austria has received full regulatory approval and has been granted a Distributors-Manufacturers License by the Austrian Federal Office for Safety in Healthcare.  Read More »
January 21, 2010
Transposagen Biopharmaceuticals, a provider of genetically modified laboratory rats, has entered into a global marketing and distribution agreement with Taconic, an animal model and service provider, in which Taconic will market and distribute Transposage  Read More »
January 20, 2010
Wacker Chemie and MorphoSys have expanded their existing collaboration for the use of Wacker’s Esetec bacterial secretion technology.  Read More »
January 20, 2010
Ricerca Biosciences has validated and implemented Watson Laboratory Information Management System (LIMS) for its bioanalysis division.  Read More »
January 20, 2010
Paula Brown Stafford, executive vice president, Integrated Clinical Services at Quintiles, has been appointed chair-elect of the board of directors of the Clinical Data Interchange Standards Consortium (CDISC), a global organization dedicated to the devel  Read More »
January 19, 2010
AMRI has received certification of its high potency research labs and GMP-manufacturing facilities in Rensselaer, NY for the safe handling of potent APIs by SafeBridge Consultants, Inc.  Read More »
January 19, 2010
Maxygen, Inc.’s majority-owned subsidiary, Perseid Therapeutics LLC, has achieved a preclinical milestone under its collaboration with Astellas Pharma, triggering a $5 million payment to Perseid.  Read More »
January 19, 2010
Halozyme Therapeutics, Inc. has signed an exclusive, worldwide, contract research collaboration with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatol  Read More »
January 18, 2010
Steve Rau has been promoted to vice president, technical operations, Tapemark.   Read More »
January 18, 2010
Medpace, a privately held, full-service CRO, has acquired Medical Consulting Dr. Schlichtiger GmbH, a Munich-based CRO that provides customized regulatory and pharmacovigilance services to pharmaceutical, biotechnology and nutritional companies.  Read More »
January 18, 2010
The FDA has extended the review period for OSI Pharmaceuticals and Genentech’s sNDA for Tarceva (erlotinib) as a first-line maintenance therapy in advanced non-small cell lung cancer (NSCLC) by an additional 90 days.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On